Cargando...
FDA Approvals of Brand-Name Prescription Drugs in 2015
I. New Pharmaceuticals: New Molecular Entities and New Biologic License Applications. II. New Combinations and New Indications. III. New Dosage Forms and New Formulations. IV. New Biosimilars, Vaccines, Viral Therapies, and Blood Products.
Gardado en:
| Publicado en: | Am Health Drug Benefits |
|---|---|
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado: |
Engage Healthcare Communications, LLC
2016
|
| Assuntos: | |
| Acceso en liña: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5013848/ https://ncbi.nlm.nih.gov/pubmed/27668042 |
| Tags: |
Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!
|